AAI Involvement

(Chicago, Illinois) May 10, 2025

ExoMira Medicine is proud to highlight the leadership of scientific co-founder Deyu Fang, MD, PhD, who served as moderator for the session “TIPT2 – Mechanisms of Tumor Control” at the American Association of Immunologists (AAI) 2025 Annual Meeting, held on May 5, 2025, in Honolulu, Hawaii.

The TIPT2 session, part of AAI’s flagship annual conference, convened top immunologists to discuss emerging discoveries in tumor-immune interactions and pathways of immune-mediated tumor suppression. Dr. Fang’s role as session moderator reflects his recognized expertise in tumor immunology and his long-standing contributions to the field.

Dr. Fang’s leadership at this premier international forum aligns with ExoMira’s mission to advance innovative immunotherapeutic strategies, including its USP22-targeted small molecule program, MIRA-1, which aims to reprogram immune resistance in solid tumors.